$CVV
CVD EQUIPMENT CORP Stock $cvv

$cvv Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000143774922007843 Filed on March 31, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$4.717M	$16.45M	$3.170M
YoY Change	48.8%	-2.8%	-42.88%
Cost Of Revenue	$4.077M	$13.91M	$3.260M
YoY Change	25.05%	-0.92%	-23.29%
Gross Profit	$640.4K	$2.539M	-$90.00K
YoY Change	-811.54%	-11.92%	-106.98%
Gross Profit Margin	13.58%	15.44%	-2.84%
Selling, General & Admin	$1.709M	$6.865M	$1.640M
YoY Change	4.23%	1.94%	-7.87%
% of Gross Profit	266.93%	270.4%
Research & Development	$114.2K	$481.2K	$70.00K
YoY Change	63.11%	29.13%	-50.0%
% of Gross Profit	17.83%	18.95%
Depreciation & Amortization	$157.2K	$742.3K	$370.0K
YoY Change	-57.51%	-46.6%	54.17%
% of Gross Profit	24.55%	29.24%
Operating Expenses	$1.824M	$7.346M	$1.720M
YoY Change	6.02%	-31.39%	-10.42%
Operating Profit	-$1.183M	-$4.807M	-$1.810M
YoY Change	-34.63%	-38.56%	187.3%
Interest Expense	-$8.590K	$261.4K	-$110.0K
YoY Change	-92.19%	-41.18%	22.22%
% of Operating Profit
Other Income/Expense, Net	$0.00	$500.0K	$210.0K
YoY Change	-100.0%	-17.13%	5.0%
Pretax Income	-$1.192M	$4.775M	-$5.310M
YoY Change	-77.56%	-162.81%	941.18%
Income Tax	-$10.00	$28.38K	$0.00
% Of Pretax Income		0.59%
Net Earnings	-$1.192M	$4.746M	-$5.310M
YoY Change	-77.56%	-178.13%	102.67%
Net Earnings / Revenue	-25.27%	28.86%	-167.51%
Basic Earnings Per Share		$0.71
Diluted Earnings Per Share	-$177.8K	$0.71	-$797.3K
COMMON SHARES
Basic Shares Outstanding	6.687M	6.688M	6.648M
Diluted Shares Outstanding		6.704M

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.65M	$16.65M	$7.700M
YoY Change	116.25%	116.25%	-11.09%
Cash & Equivalents	$16.70M	$16.65M	$7.700M
Short-Term Investments
Other Short-Term Assets	$493.8K	$493.8K	$709.2K
YoY Change	-30.37%	-30.45%	-3.29%
Inventory	$1.225M	$1.225M	$1.124M
Prepaid Expenses
Receivables	$1.446M	$3.985M	$1.048M
Other Receivables	$715.6K	$715.6K	$720.0K
Total Short-Term Assets	$23.07M	$23.07M	$11.79M
YoY Change	95.68%	95.68%	-16.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.26M	$12.26M	$28.84M
YoY Change	-57.49%	-57.49%	-10.15%
Goodwill
YoY Change
Intangibles	$182.8K		$288.7K
YoY Change	-36.66%		-34.57%
Long-Term Investments
YoY Change
Other Assets	$9.570K	$9.570K	$13.75K
YoY Change	-30.39%	-4.3%	0.0%
Total Long-Term Assets	$12.45M	$12.45M	$29.15M
YoY Change	-57.27%	-57.28%	-10.48%
TOTAL ASSETS
Total Short-Term Assets	$23.07M	$23.07M	$11.79M
Total Long-Term Assets	$12.45M	$12.45M	$29.15M
Total Assets	$35.52M	$35.52M	$40.94M
YoY Change	-13.22%	-13.23%	-12.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.161M	$1.161M	$817.9K
YoY Change	41.99%	41.63%	52.77%
Accrued Expenses	$1.759M	$1.759M	$1.409M
YoY Change	24.83%	24.75%	-25.95%
Deferred Revenue	$1.650M		$786.7K
YoY Change	109.8%		-65.43%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.766M	$1.766M	$690.0K
YoY Change	155.87%	155.87%	2.99%
Total Short-Term Liabilities	$6.336M	$6.336M	$3.704M
YoY Change	71.05%	71.25%	-31.25%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$13.11M
YoY Change	-100.0%	-100.0%	15.2%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$13.11M
YoY Change	-100.0%	-100.0%	15.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.336M	$6.336M	$3.704M
Total Long-Term Liabilities	$0.00	$0.00	$13.11M
Total Liabilities	$6.336M	$6.336M	$16.81M
YoY Change	-62.31%	-62.31%	0.27%
SHAREHOLDERS EQUITY
Retained Earnings	$1.844M		-$2.903M
YoY Change	-163.51%		-191.51%
Common Stock	$27.34M		$27.03M
YoY Change	1.17%		0.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$29.19M	$29.19M	$24.13M
YoY Change
Total Liabilities & Shareholders Equity	$35.52M	$35.52M	$40.94M
YoY Change	-13.22%	-13.23%	-12.39%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$1.192M	$4.746M	-$5.310M
YoY Change	-77.56%	-178.13%	102.67%
Depreciation, Depletion And Amortization	$157.2K	$742.3K	$370.0K
YoY Change	-57.51%	-46.6%	54.17%
Cash From Operating Activities	-$697.4K	-$4.273M	$60.00K
YoY Change	-1262.27%	277.19%	-97.74%
INVESTING ACTIVITIES
Capital Expenditures	-$22.68K	$235.6K	-$380.0K
YoY Change	-94.03%	-85.06%	-33.33%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$23.08M
YoY Change
Cash From Investing Activities	-$22.68K	$22.84M	-$380.0K
YoY Change	-94.03%	-1548.15%	-33.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$9.615M
YoY Change		1333.05%
Cash From Financing Activities	-75.00K	-$9.615M	-160.0K
YoY Change	-53.13%	-651.02%	-5.88%
NET CHANGE
Cash From Operating Activities	-697.4K	-$4.273M	60.00K
Cash From Investing Activities	-22.68K	$22.84M	-380.0K
Cash From Financing Activities	-75.00K	-$9.615M	-160.0K
Net Change In Cash	-795.0K	$8.952M	-480.0K
YoY Change	65.63%	-1027.75%	-125.0%
FREE CASH FLOW
Cash From Operating Activities	-$697.4K	-$4.273M	$60.00K
Capital Expenditures	-$22.68K	$235.6K	-$380.0K
Free Cash Flow	-$674.7K	-$4.508M	$440.0K
YoY Change	-253.34%	66.36%	-86.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	500000	USD
CY2021	dei	Auditor Location AuditorLocation	Melville, NY
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6723438
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6723438
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6678698
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6678698
CY2021Q4	cvv	Number Of Wholly Owned Subsidiaries NumberOfWhollyOwnedSubsidiaries	5	pure
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	481000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	373000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2500000	USD
CY2020Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	500000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P0Y7M6D
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1650426	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	66786	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	27277154	USD
CY2020Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	690667	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	372648	USD
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16651371	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7699335	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1446354	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1047728	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2538373	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	494281	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	1225015	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1123839	USD
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	715599	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	715599	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	493788	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	709175	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	23070500	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	11789957	USD
CY2021Q4	cvv	Property Plant And Equipment Excluding Construction In Progress Net PropertyPlantAndEquipmentExcludingConstructionInProgressNet	12261321	USD
CY2020Q4	cvv	Property Plant And Equipment Excluding Construction In Progress Net PropertyPlantAndEquipmentExcludingConstructionInProgressNet	28843563	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	182838	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	288657	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9570	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13748	USD
CY2021Q4	us-gaap	Assets Assets	35524229	USD
CY2020Q4	us-gaap	Assets Assets	40935925	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1161381	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	817933	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1758939	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1409039	USD
CY2021Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1765508	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	786657	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6336254	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3704296	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13106057	USD
CY2021Q4	us-gaap	Liabilities Liabilities	6336254	USD
CY2020Q4	us-gaap	Liabilities Liabilities	16810353	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	67234	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	26961684	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1843587	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2902898	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	29187975	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	24125572	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35524229	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40935925	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	16446813	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	16920219	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	13907974	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	14037813	USD
CY2021	us-gaap	Gross Profit GrossProfit	2538839	USD
CY2020	us-gaap	Gross Profit GrossProfit	2882406	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	481186	USD
CY2021	us-gaap	Selling Expense SellingExpense	810074	USD
CY2020	us-gaap	Selling Expense SellingExpense	580468	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3599322	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6054832	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6153925	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	7346092	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	10706363	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-4807253	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-7823957	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	5994	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	62667	USD
CY2021	us-gaap	Interest Expense InterestExpense	261377	USD
CY2020	us-gaap	Interest Expense InterestExpense	444337	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	6894109	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2443418	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	499971	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	603320	USD
CY2021	cvv	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	9582115	USD
CY2020	cvv	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	221650	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4774862	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7602307	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28377	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1527355	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4746485	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-6074952	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.71
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6688087
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6640272
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6703709
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6640272
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	29957845	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-6074952	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	242679	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	24125572	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4746485	USD
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	315918	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	29187975	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4746485	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-6074952	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3599322	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	6894109	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2443418	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	315918	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	242679	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	742287	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1389145	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	140044	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	398626	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1357765	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	2044092	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-18671	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	101176	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-585874	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	715599	USD
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-219565	USD
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-24162	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	343448	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	282539	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	377349	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-493819	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	863769	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1488579	USD
CY2021	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-9019085	USD
CY2020	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	4942204	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4272600	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1132748	USD
CY2021	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	23075477	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	235595	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1577175	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	22839882	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1577175	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2415970	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	9615246	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	670965	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9615246	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1745005	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8952036	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-964918	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7699335	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8664253	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16651371	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7699335	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	28391	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	3040	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	261376	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	445109	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16700000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Use of Estimates</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company’s significant estimates are the accounting for certain items such as revenues on long-term contracts recognized on the input method, valuation of inventories at the lower of cost or net realizable value; allowance for doubtful accounts receivable; valuation allowances for deferred tax assets, estimated lives and impairment considerations of long-lived assets and valuation of stock-based compensation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2020Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3600000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	112310	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	124550	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7700000	USD
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	7000000.0	USD
CY2020Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1000000.0	USD
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	8613000	USD
CY2020Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	5822000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Concentration of Credit Risk</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable. The Company places its cash equivalents with financial institutions and invests its excess cash primarily in treasury bills, certificates of deposit or deposit accounts. The Company has established guidelines relative to credit ratings and maturities that seek to maintain stability and liquidity.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company sells products and services to various companies across several industries in the ordinary course of business. The Company routinely assesses the financial strength of its customers and maintains allowances for anticipated losses based upon historical experience.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	59000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	164000	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	16447000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	16920000	USD
CY2021	cvv	Contract With Customer Cumulative Catchup Adjustment To Revenue Change In Estimate Of Transaction Price And Input Costs ContractWithCustomerCumulativeCatchupAdjustmentToRevenueChangeInEstimateOfTransactionPriceAndInputCosts	6500000	USD
CY2021Q4	cvv	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	7418433	USD
CY2020Q4	cvv	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	4464471	USD
CY2021Q4	cvv	Estimated Earnings EstimatedEarnings	5071039	USD
CY2020Q4	cvv	Estimated Earnings EstimatedEarnings	2087396	USD
CY2021Q4	cvv	Costs And Estimated Earnings On Uncompleted Contracts CostsAndEstimatedEarningsOnUncompletedContracts	12489472	USD
CY2020Q4	cvv	Costs And Estimated Earnings On Uncompleted Contracts CostsAndEstimatedEarningsOnUncompletedContracts	6551867	USD
CY2021Q4	cvv	Billings To Date BillingsToDate	11408605	USD
CY2020Q4	cvv	Billings To Date BillingsToDate	6212229	USD
CY2021Q4	cvv	Net Cost In Excess Of Billings NetCostInExcessOfBillings	1080867	USD
CY2020Q4	cvv	Net Cost In Excess Of Billings NetCostInExcessOfBillings	339638	USD
CY2021Q4	cvv	Deferred Revenues Related To Contracts DeferredRevenuesRelatedToContracts	192920	USD
CY2020Q4	cvv	Deferred Revenues Related To Contracts DeferredRevenuesRelatedToContracts	632014	USD
CY2021Q4	cvv	Contract Liability In Excess Of Contract Assets ContractLiabilityInExcessOfContractAssets	-887947	USD
CY2020Q4	cvv	Contract Liability In Excess Of Contract Assets ContractLiabilityInExcessOfContractAssets	292376	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2538373	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	494281	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1650426	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	786657	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	742287	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28843563	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1389145	USD
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	112310	USD
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	124550	USD
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1030955	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	928221	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	194060	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	195618	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	1225015	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1123839	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21702817	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	38071129	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9441496	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9227566	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12261321	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	665976	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	483138	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	182838	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	887853	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	599196	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	288657	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	34318	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	19756	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	16214	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	16214	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	8246	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	88090	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	182838	USD
CY2021Q4	cvv	Longterm Debt Including Acquisition Related Contingent Payment Total LongtermDebtIncludingAcquisitionRelatedContingentPaymentTotal	1765508	USD
CY2020Q4	cvv	Longterm Debt Including Acquisition Related Contingent Payment Total LongtermDebtIncludingAcquisitionRelatedContingentPaymentTotal	13796724	USD
CY2021Q4	cvv	Longterm Debt Including Acquisition Related Contingent Payment Current Maturities LongtermDebtIncludingAcquisitionRelatedContingentPaymentCurrentMaturities	-1765508	USD
CY2020Q4	cvv	Longterm Debt Including Acquisition Related Contingent Payment Current Maturities LongtermDebtIncludingAcquisitionRelatedContingentPaymentCurrentMaturities	-690667	USD
CY2021Q4	cvv	Longterm Debt Including Acquisition Related Contingent Payment Excluding Current Maturities LongtermDebtIncludingAcquisitionRelatedContingentPaymentExcludingCurrentMaturities	0	USD
CY2020Q4	cvv	Longterm Debt Including Acquisition Related Contingent Payment Excluding Current Maturities LongtermDebtIncludingAcquisitionRelatedContingentPaymentExcludingCurrentMaturities	13106057	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1765508	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	1765508	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	722720	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	712683	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1671893	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1527355	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6688087
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6640272
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	15622
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6703709
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6640272
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	618500
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	265000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	417000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	377000
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	287000
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	417000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2990093	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3381133	USD
CY2020Q1	us-gaap	Income Tax Receivable IncomeTaxReceivable	1500000	USD
CY2021Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	7000000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	14978	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-1528305	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	13399	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	950	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	28377	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-1527355	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28377	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	12926	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	35442	USD
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	6620	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	6969	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	243000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1719598	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	148958	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	211363	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	141079	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	89626	USD
CY2021Q4	cvv	Deferred Tax Assets Interest Expense Carryforwards DeferredTaxAssetsInterestExpenseCarryforwards	0	USD
CY2020Q4	cvv	Deferred Tax Assets Interest Expense Carryforwards DeferredTaxAssetsInterestExpenseCarryforwards	223768	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	808163	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	925912	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	94235	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	12248	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3606594	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3937609	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	616501	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	556476	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2990093	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3381133	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1002721	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1596485	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-346209	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	883796	USD
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-115863	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	70492	USD
CY2021	cvv	Effective Income Tax Reconciliation Operating Loss Carryforward EffectiveIncomeTaxReconciliationOperatingLossCarryforward	0	USD
CY2020	cvv	Effective Income Tax Reconciliation Operating Loss Carryforward EffectiveIncomeTaxReconciliationOperatingLossCarryforward	-1527355	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	5787	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-36832	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	56761	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	64266	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	51820	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	743295	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28377	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1527355	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	316000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	333500
CY2021Q4	us-gaap	Share Price SharePrice	4.13
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	4.13
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.67	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0136	pure
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	618500
CY2021	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	12.01
CY2021	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	15.00
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	100000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.00
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	100000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	15.00
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	730000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y5M26D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	160000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	113000	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	pure
CY2021Q4	us-gaap	Assets Assets	35524000	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	16447000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-4807000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	6894000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4775000	USD
CY2020Q4	us-gaap	Assets Assets	40936000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	16920000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-7824000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7602000	USD

Files In Submission

Name	View Source	Status
0001437749-22-007843-index-headers.html	Edgar Link	pending
0001437749-22-007843-index.html	Edgar Link	pending
0001437749-22-007843.txt	Edgar Link	pending
0001437749-22-007843-xbrl.zip	Edgar Link	pending
cvv-20211231.xsd	Edgar Link	pending
cvv-20211231_cal.xml	Edgar Link	unprocessable
cvv-20211231_def.xml	Edgar Link	unprocessable
cvv-20211231_lab.xml	Edgar Link	unprocessable
cvv-20211231_pre.xml	Edgar Link	unprocessable
cvv20211231_10k.htm	Edgar Link	pending
cvv20211231_10k_htm.xml	Edgar Link	completed
ex_351339.htm	Edgar Link	pending
ex_351340.htm	Edgar Link	pending
ex_351341.htm	Edgar Link	pending
ex_351342.htm	Edgar Link	pending
ex_351372.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CVV
CVD EQUIPMENT CORP Stock $cvv

2021 Q4 Form 10-K Financial Statement

#000143774922007843 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVV CVD EQUIPMENT CORP Stock $cvv

2021 Q4 Form 10-K Financial Statement

#000143774922007843 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVV
CVD EQUIPMENT CORP Stock $cvv